Lactulose, disaccharides and colonic flora. Clinical consequences

Drugs
M R Clausen, P B Mortensen

Abstract

Lactulose is one of the most frequently utilised agents in the treatment of constipation and hepatic encephalopathy because of its efficacy and good safety profile. The key to understanding the possible modes of action by which lactulose achieves its therapeutic effects in these disorders lies in certain pharmacological phenomena: (a) lactulose is a synthetic disaccharide that does not occur naturally; (b) there is no disaccharidase on the microvillus membrane of enterocytes in the human small intestine that hydrolyses lactulose; and (c) lactulose is not absorbed from the small intestine. Thus, the primary site of action is the colon in which lactulose is readily fermented by the colonic bacterial flora with the production of short-chain fatty acids and various gases. The purpose of this review is to focus on some pertinent basic aspects of the clinical pharmacology of lactulose and to discuss the possible mechanisms by which lactulose benefits patients with constipation and hepatic encephalopathy.

Citations

Jan 20, 2004·Radiographics : a Review Publication of the Radiological Society of North America, Inc·David C MadoffRichard R Saxon
Oct 6, 2011·European Journal of Gastroenterology & Hepatology·Ming LuoWu-Kui Cao
Apr 26, 2001·The British Journal of Nutrition·P Marteau, B Flourié
Jun 4, 2010·Drugs·Paula V PhongsamranAngela Rosenblatt
Mar 16, 2007·Digestive Diseases and Sciences·Andrew SzilagyiXiaoqing Xue
Jan 20, 2000·The New England Journal of Medicine·M Shannon
Jun 11, 2008·Journal of Clinical Gastroenterology·Anish A Sheth, Guadalupe Garcia-Tsao
Feb 15, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Katrin SchütteAlessandro Chiodini
Aug 10, 2010·Critical Care Nursing Clinics of North America·Keith J FosterCharles J Turck
May 13, 2008·Gastroenterology·Arun J SanyalVincente Arroyo
May 4, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Steven F Solga, Anna Mae Diehl
Mar 25, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ravindra A KalePonnada A Narayana
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Srinivasa PrasadRitesh Agarwal
Feb 21, 2008·Alimentary Pharmacology & Therapeutics·P JouëtB Coffin
Apr 20, 2005·Lancet·Andres T Blei
Jan 15, 2015·Critical Reviews in Biotechnology·Siti A Zaman, Shahrul R Sarbini
Jun 5, 2015·Journal of Clinical and Experimental Hepatology·Praveen Sharma, Barjesh C Sharma
Jun 5, 2015·Journal of Clinical and Experimental Hepatology·Rahul RaiRadha K Dhiman
Sep 25, 2003·Alcoholism, Clinical and Experimental Research·Sémia H ZidiKalle Jokelainen
Jul 27, 2001·The American Journal of Gastroenterology·A T BleiUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Mar 15, 2012·British Journal of Community Nursing·Alexandra Carlin, David Justham
Dec 31, 2005·Metabolic Brain Disease·Kai O Lindros, Harri A Järveläinen
Dec 4, 2014·World Journal of Gastroenterology : WJG·Giulia MalaguarneraMichele Malaguarnera
Dec 17, 2019·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Michelle KozenieckiBrittney Patterson
Oct 5, 2019·World Journal of Pediatrics : WJP·Elpiniki NikolaouChristos Shammas
Apr 24, 2013·Hepatitis Monthly·Abbas Ali Imani FooladiSeyed Moayed Alavian
Apr 26, 2001·The British Journal of Nutrition·O Murphy
Aug 21, 2018·The Journal of Veterinary Medical Science·Kazushi AzumaHajime Tsujimoto
Mar 5, 2013·Metabolic Brain Disease·Praveen Sharma, Barjesh Chander Sharma
Jan 28, 2021·Scientific Reports·Veronika RackayováCristina Cudalbu
Mar 28, 2021·Clinical Journal of Gastroenterology·Justin RoyIan Schreibman
Aug 14, 2021·Frontiers in Nutrition·Tarkan KarakanGwendolyn Janssen-van Solingen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.